Osia Hyper Reta. (OSIAHYPER)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 0.24 offers a deep discount to stated book value of ₹24.54 per share
• ROCE of 14.72% suggests decent capital productivity despite retail pressures
• Debt/Equity of 0.40 indicates moderate leverage, not excessive debt
• Promoter holding of 46.62% provides some alignment with minority shareholders
• Latest quarter still profitable with net profit of ₹4 Cr on sales of ₹383 Cr

Concerns

• Profit growth down 52.05% and sales growth down 5.89% show clear operational deterioration
• Piotroski F-score of 3/9 points to weak financial health and possible red flags
• Zero dividend yield offers no return while waiting for a recovery
• Huge 52-week range from ₹2.41 to ₹33.08 signals high volatility and uncertain market confidence

AI Analysis

At first glance, this looks like a Graham-style bargain. Price ₹5.95, book value ₹24.54, and a P/B of 0.24 — the market is valuing the business at less than a quarter of its stated net worth. That is a wide margin of safety if the book value is trustworthy. But cheapness alone is not enough. The latest quarter shows sales of ₹383 Cr and net profit of only ₹4 Cr, which is thin for a retail balance sheet. Trends are going the wrong way: sales growth is -5.89% and profit growth is -52.05%. A Piotroski F-score of 3 out of 9 reinforces my worry that financial health is weakening. I respect the ROCE of 14.72% and the debt-to-equity of 0.40 is manageable, but zero dividend yield means I am not being paid to wait. Promoter holding at 46.62% is decent, yet in retail, the moat is usually weak and competition is brutal. The 52-week range of ₹2.41 to ₹33.08 shows how violently the market has repriced this stock. This could be a valuable asset play if assets are real and management can stabilize operations, but it could also be a value trap if the deterioration continues. I need evidence of operational stabilisation before putting money to work. For now, I would keep it on the watchlist, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer